Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway

Despite the increase in the global prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD), no approved drug currently exists for the disease. Poria cocos (Schw.) Wolf (P. cocos) is a medicinal mushroom belonging to a family of polyporaceae widely used in TCM clinics to protect th...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jinbiao, Yang, Yu, Zhang, Fan, Li, Yanjuan, Li, Xiaosi, Pu, Xuemei, He, Xudong, Zhang, Mei, Yang, Xinxing, Yu, Qiuman, Qi, Yan, Li, Xuefang, Yu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581278/
https://www.ncbi.nlm.nih.gov/pubmed/36278226
http://dx.doi.org/10.3389/fphar.2022.1007274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581278/
https://www.ncbi.nlm.nih.gov/pubmed/36278226
http://dx.doi.org/10.3389/fphar.2022.1007274

Ejemplares similares